The Global Flu Vaccine Market accounted for US$ 4572.3 million in 2020 and is estimated to be US$ 8179.4 million by 2030 and is anticipated to register a CAGR of 6.0%. Influenza virus is continuously circulating causing regional epidemics and outbreaks, leading to thousands of deaths. For instance, according to Centers for Disease Control and Prevention (CDC) more than 13 million flu cases are recorded so far in the time-frame of 2019-20. World Health Organization (WHO) recommended numerous licensed seasonal influenza vaccines. The rising demand for vaccine is anticipated to surge the global influenza vaccine market.
The report " Global Flu Vaccine Market, By Type (Split Virus Vaccines, Subunit Vaccines, and Others), By Application (For Children and For Adults and Children over 3 years), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”
Key Highlights:
- In 2020, Abbott launched a new inactivated quadrivalent vaccine for influenza, first of its kind sub-unit vaccine offering protection against this strains in India. Approved vaccine is for below 3 years.
- In August 2020, AstraZeneca increases its manufacturing effects to deliver more FluMIST by collaborating with top key players such as GlaxoSmithKline, Sanofi, Seqirus in efforts to increase the manufacturing of vaccine
Analyst View:
Increasing investment and the growing government funding have boosted research and development of pharmaceutical companies which drives the market. Growing demand for pediatric vaccine as highest market size is covered among the age group. Quadrivalent vaccines are in great demands as they protect from four strains of the influenza virus through a single vaccine which boost the market of flu vaccine.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Flu Vaccine Market, By Type (Split Virus Vaccines, Subunit Vaccines, and Others), By Application (For Children and For Adults and Children over 3 years), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”
To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Global-Flu-Vaccine-Market-By-2230
Key Market Insights from the report:
The Global Flu Vaccine Market accounted for US$ 4572.3 million in 2020 and is estimated to be US$ 8179.4 million by 2030 and is anticipated to register a CAGR of 6.0%. The Global Flu Vaccine Market is segmented based on the type, application and region.
- By Type, the Global Flu Vaccine Market is segmented into Split Virus Vaccines, Subunit Vaccines, and Others
- By Application, the market is segmented in For Children and For Adults and Children over 3 years
- By region, the Global Flu Vaccine Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Competitive Landscape:
The key players operating in the Global Flu Vaccine Market include CSL Itd, GSK LLc, Sanofi Pasteur, Mylan N.V., AstraZeneca PLC, Pfizer Inc., and Johnson & Johnson Company.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
To know more
Contact Us:
Sales
Prophecy Market Insights
Email- [email protected]
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza.
A new version of the vaccine is developed twice a year as the influenza virus rapidly changes.
Evidence in adults over 65 years old is poor.
Vaccinating children may protect those around them.Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc.
And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
Market Analysis and Insights: Global Flu Vaccine MarketIn 2020, the global Flu Vaccine market size was US$ 5154 million and it is expected to reach US$ 7293.3 million by the end of 2027, with a CAGR of 4.8% during 2021-2027.Global Flu Vaccine Scope and Market SizeFlu Vaccine market is segmented by region, by country, company, type, application and by sales channels.
Swine flu is infection of the respiratory system caused by influenza viruses.
These viruses also infect the respiratory system of pigs causing barking cough, decrease in appetite, nasal secretions, and listless behavior.
In April 2009, swine flu outbreak was first detected in Mexico and was caused due to the H1N1 virus.Read Report Overview - https://www.transparencymarketresearch.com/swine-flu-vaccine-market.html Symptoms of swine flu infection in humans are similar to influenza infection; these include cough, nasal secretions, headache, fatigue, and fever (temp.
The gestation period of the disease is around one to four days.
Vaccination is the best way to prevent the disease.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=33686 Influenza vaccine makes a significant division of global vaccine market.
In terms of end-user, the market can be divided into hospital pharmacies, retail pharmacies, online pharmacies, and clinic & vaccination centers.
DPI Research offers a latest published report on “United States Influenza Vaccines Market” delivering key insights and providing a competitive advantage to clients through a detailed report.
The report contains 205 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.DPI Research Offering Flat 30% off on All Research Reports on Year End.
Use Coupon Code : DPI30The United States influenza vaccines market size to cross US$ 5.5 Billion by 2028.Download Report Sample: https://dpiresearch.com/request-a-free-sample-report/This new market report presents an inclusive study of the entire United States influenza vaccines market.
The report also provides up–to–date market size data for the period 2015 – 2020 and an illustrative forecast to 2028 covering key market aspects like market value and volume for influenza vaccines.Some of the Major Factors Contributing to the Growth of the Market:The Surge in the COVID–19 PandemicIncreased Disease AwarenessIntroduction of the Quadrivalent Influenza VaccinesIncreasing Research and DevelopmentExpanded Recommendations by Governmental and Advisory Bodies to be Vaccinated against Influenza VaccinesKey Highlights:The United States Rises to Become Largest Influenza Vaccines MarketThe Demand for the Flu Vaccine is Expected to Increase in the Forecast Period Because of the COVID–19 Pandemic SurgeEpiVax to Design Antigens for Next–Generation Flu VaccineVersatope Therapeutics, Inc Awarded a Contract worth up to US$17.9 Million from the National Institute of Allergy and Infectious Diseases (NIAID)Enquire for customization in Report @: https://dpiresearch.com/services/custom-research-services-providing-focused-comprehensive-tailored-research/This Comprehensive U.S Influenza Vaccines Report Provides:The Market Size of the United States Influenza Vaccines Market with Seven Years ForecastEvaluates the United States Overall Persons Being Vaccinated with Influenza Vaccines with Seven Years ForecastScrutinizes the United States Children Being Vaccinated with Influenza Vaccines with Seven Years ForecastStudies the United States Adults Being Vaccinated with Influenza Vaccines with Seven Years ForecastDelivers Comprehensive Insights on the Latest Pricing Trends and AnalysisCovers a Broad Analysis of the US Influenza Vaccines Production, Supply, and Allocation (By Companies)Delivers a Complete Outline of the US Influenza Vaccines Distribution and DemandStudies the Latest Effectiveness of the Influenza Vaccines in the United StatesThoroughly Assessment of the Rapid Diagnostic Testing for the Management of InfluenzaMeticulously Assesses of the Distribution Channel and Technique of the Influenza Vaccination in the United StatesDetailed Insights into the Regulatory Framework of the United States Influenza Vaccines MarketFeatures Reimbursement Patterns of the United States Influenza Vaccines MarketTracks Competitive Developments, Approaches, Recent Industry Developments, Mergers & Acquisitions.
Collaboration, Distribution, Exclusive, and Licensing AgreementAn Insightful Investigation has been done on Promising Influenza Vaccines in the Clinical DevelopmentAnalyses the Most Recent Clinical Trials of the Influenza Vaccines between 2019 and 2020Delivers an In–Depth Analysis of Evolving Market Trends, Drivers, and Restraints of the United States Influenza Vaccines MarketA Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolio, Promising Vaccines in the Clinical Development, Influenza Vaccines Market Value, and Recent DevelopmentAn Insightful Analysis of the Emerging Players Along with the Analysis of their Promising Vaccines in the Clinical Development, Phase, Platform Technology, and Recent DevelopmentThe Key and Emerging Market Players for the U.S Influenza Vaccines Market are Listed Below Sanofi PasteurGlaxoSmithKline (GSK)Seqirus (CSL Limited)AstraZenecaEpiVax, IncNovavaxMedicagoModerna IncPneumagenDaiichi–SankyoAltimmuneFluGenImutexVersatope Therapeutics, IncBiondVax Pharmaceuticals Ltd.Key Questions Answered in this Report:What is the current scenario of the U.S. influenza vaccines market?What is the total market size and forecast (until 2028) for the S. influenza vaccines market?How many persons being vaccinated with influenza vaccines in the US during 2015 – 2028?How effective is influenza(flu) shot for 2020?What percentage of the United States do people get the flu vaccine?What are the key marketed influenza vaccines available in the United States?What are the major drivers of the United States influenza vaccines market?What are the major inhibitors of the United States influenza vaccines market?What is the reimbursement pattern in the United States influenza vaccines market?What is the regulatory framework in the United States influenza vaccines market?What are the major deals and agreement happenings in the United States influenza vaccines market?What are the upcoming influenza vaccines that will have a significant impact on the market in the future?Who are the top market players?
What are their happenings, clinical development, platform technology, phase, and current developments?How is the market predicted to develop in the future?For More Information@ https://dpiresearch.com/u-s-influenza-flu-vaccines-market/The report is readily available and can be dispatched immediately after payment confirmation.Would like to place an order or any question, please feel free to contact at [email protected] of the Report:DPI Research provides customization of the report as per your need.
A recent study found that less than 25% of daycare and preschool providers need to enrolled children receive the flu vaccine.
The flu vaccine can reduce children's risk of flu-related influence care unit admission by 74%, and adult flu-related intensive care admission by 82%.
A primary humidifier can control the spread of the flu in your daycare or preschool.
Read this full blog at https://bit.ly/3huh4dw
